Shares of Moderna rose 3.54% to $115.35 at 11:44 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ Composite is sliding 0.13% to $12,882.81, after two successive sessions in a row of gains. This seems, up to now, a somewhat negative trend trading session today.
Moderna’s last close was $111.40, 54.75% under its 52-week high of $178.50.
Moderna’s sales growth is 1841.7% for the current quarter and 19117.5% for the next. The company’s growth estimates for the current quarter is a negative 13.5% and positive 660% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s last day, last week, and last month’s average volatility was a negative 10.76%, a negative 4.82%, and a positive 0.17%, respectively.
Moderna’s last day, last week, and last month’s high and low average amplitude percentage was 10.65%, 10.59%, and 10.66%, respectively.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $115.35 at 11:44 EST, way below its 52-week high of $178.50 and way higher than its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s worth is below its 50-day moving average of $124.05 and way higher than its 200-day moving average of $82.87.